Table 1.
Advantages | Disadvantages | |
---|---|---|
Sanger or population sequencing | Well-established, standardised and scientifically validated; highly reproducible; widely available | Inability to detect minority viral variants occurring at a frequency < 15–20% in a patient’s sample; labour intensive and time consuming |
Next-generation ultradeep sequencinga | Able to detect low abundance viral variants occurring at a frequency between ~ 2% and 15%; capable of quantifying the relative frequency of each variant; high throughput and low cost per sample | Financial, infrastructural and logistical challenges impede widespread adoption; generates large amount of data and complex bioinformatic methodology is required for interpretation; uncertain clinical significance of variants detected at low frequency |
aTypically using the Illumina sequencing technology